Ancient DNA Analysis Sheds Light on the Early Peopling of South America

Using DNA from two ancient humans unearthed in two different archaeological sites in northeast Brazil, researchers have unraveled the deep demographic history of South America at the regional level with some surprising results. Not only do they provide new genetic evidence supporting existing archaeological data of the north-to-south migration toward South America, they also have discovered migrations in the opposite direction along the Atlantic coast – for the first time. Among the key findings, they also have discovered evidence of Neanderthal ancestry within the genomes of ancient individuals from South America. Neanderthals ranged across Eurasia during the Lower and Middle Paleolithic. The Americas were the last continent to be inhabited by humans.

Smidt Heart Institute Experts to Present the Latest in Heart Research, Patient Care

Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.

Dissecting the Ecology of Microalgae and Bacteria across Time and Space

Microalgae play an important role in the Earth’s climate, converting carbon dioxide into solid carbon. This research sought new ways to study these microalgae and their associated bacterial communities across time and space. The researchers created a new co-culture method called a “porous microplate” that passes nutrients and molecules associated with metabolism between culture cells while blocking physical contact between algae in adjacent wells.

FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the treatment of adult patients with the family of blood diseases known as histiocytic neoplasms (HN). These diseases include Erdheim-Chester disease, Rosai-Dorfman disease, and Langerhans cell histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2, currently approved to treat melanoma.

Youth Voter Registration Is Up Compared to 2018—Especially in Key Battlegrounds

With one week to go until the 2022 midterm elections, there are 6% more young people ages 18-24 registered to vote in the United States than there were in November 2018—based on the 41 states for which data is available. This data includes major increases in electoral battlegrounds where CIRCLE research suggests young people could influence election results.

UCI School of Social Ecology welcomes Andrew Yang for “Leading the Change Distinguished Speaker Series”

EVENT:  The School of Social Ecology at the University of California, Irvine, welcomes Andrew Yang for its “Leading the Change Distinguished Speaker Series.” The businessman, attorney, lobbyist, political candidate and co-founder of the Forward Party will speak on “Technology, Democracy and the Future.” Event is free and open to the public, but registration is required here: https://socialecology.

GW Experts on Election Security and Political Violence Ahead of the Midterms

“Election officials in the United States have been alerted to safe-proof their voting systems and be vigilant about political violence amid a “very complex threat environment,” top U.S. cybersecurity official Jen Easterly said on Sunday in the wake of an…

Youngest Girls Who Get Pregnant Have Highest Risk of Poor Outcomes, Study Finds

Pregnant teens in the U.S. have long been known to face increased health risks and pregnancy complications, but a new study for the first time finds that girls ages 13 or younger who get pregnant face even greater risks. These very young girls are significantly more likely to experience preterm birth, cesarean delivery, and admission to the intensive care unit (ICU) compared to older pregnant teens.

New Optimism on Myelodysplastic Syndromes

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment approaches for myelodysplastic syndromes (MDS), which are rare and often deadly bone…

Cinco avanços fundamentais nos transplantes de medula óssea

Nas seis décadas em que o transplante de sangue e medula tem sido usado para tratar pacientes com câncer no sangue, esse tratamento experimental tornou-se uma ferramenta vital de combate ao câncer. A Mayo Clinic, em Rochester, Minnesota, está celebrando a marca de 10 mil transplantes sanguíneos e de medula usados para o tratamento de cânceres sanguíneos e de doenças relacionadas.

خمسة تطورات رئيسية في عمليات زراعة نخاع العظم

مدينة روتشستر، ولاية مينيسوتا. – على مدار الستة عقود الماضية منذ بداية استخدام عمليات زراعة الدم والنخاع لعلاج المرضى المصابين بسرطان الدم، أصبح هذا العلاج التجريبي أداة حيوية لمكافحة السرطان. تحتفل مايو كلينك في مدينة روتشستر بولاية مينيسوتا بإجراء 10,000 عملية زراعة دم ونخاع لعلاج سرطانات الدم والاضطرابات ذات الصلة.

Collegiate students fired up to protect virtual solar facility from cyberattack

Cybersecurity professionals are in high demand. The Department of Energy tasks Argonne National Laboratory with challenging and inspiring college-age students to compete against one another to outsmart cyberattackers in a simulated threat scenario.

New technique makes gene editing at scale possible in animals, turning years of work into days and making new kinds of genetic experiments possible

A new gene editing technique developed by University of Oregon researchers compresses what previously would have been years of work into just a few days, making new kinds of research possible in animal models.